Document is current
Any future updates will be listed below
-
Authors
Toell, Thomas
Boehme, Christian
Mayer, Lukas
Krebs, Stefan
Lang, Clemens
Willeit, Karin
Prantl, Barbara
Knoflach, Michael
Rumpold, Gerhard
Schoenherr, Gudrun
Griesmacher, Andrea
Willeit, Peter
Ferrari, Julia
Lang, Wilfried
Kiechl, Stefan
Willeit, Johann http://orcid.org/0000-0003-4083-0466
-
Funding
Funding for this research was provided by:
University Hospital
Tyrolean Health Insurance Company
Tyrol Health Care Funds
Boehringer Ingelheim
Otto Bock
Bayer Healthcare
Sanofi Aventis
- License Information
-
More Information
Article History
Received: 22 June 2018
Accepted: 21 October 2018
First Online: 6 November 2018
Ethics approval and consent to participate
: The study protocol was approved by the local Ethics Committee of the Medical University of Innsbruck in October 2013 (recruitment start, January 2014) and the local Ethics Committee of the Hospital St. John of God Vienna in December 2014 (recruitment start, December 2014). All patients gave their written informed consent for participation in the trial and the use of bio-samples and data for future research projects targeting etiology, complications, outcome, prognosis, and management of ischaemic stroke and TIA.
: Not applicable.
: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
